Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2
Sign Up to like & getrecommendations! Published in 2022 at "Molecules"
DOI: 10.3390/molecules27165134
Abstract: Arginases are often overexpressed in human diseases, and they are an important target for developing anti-aging and antineoplastic drugs. Arginase type 1 (ARG1) is a cytosolic enzyme, and arginase type 2 (ARG2) is a mitochondrial… read more here.
Keywords: arginase; virtual screening; arginase type; potential arginase ... See more keywords